查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750665

全球表觀遺傳學診斷市場：市場規模、市場佔有率、趨勢分析（按產品、技術、應用、最終用途和地區）、細分市場預測（2025-2030 年）

Epigenetics Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

表觀遺傳學診斷市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球表觀遺傳診斷市場預計到2030年將達到391.5億美元，2025年至2030年期間的複合年成長率為15.5%。

這一成長歸因於表觀遺傳學研發投入、資金籌措和核准的增加，以及重度憂鬱症(MDD) 盛行率的上升。根據世界衛生組織 (WHO) 的數據，到 2023 年，約有 5% 的成年人將患有憂鬱症。此外，美國國家生物技術資訊中心 (NCBI) 在 2022 年發表的一項研究報告稱，全球約有 2.8 億人患有 MDD。表觀遺傳學在藥物研發上的應用正在不斷擴展，基因組序列測定也越來越低。此外，表觀遺傳藥物研發相關技術的進步也促進了這一成長。

此外，公共和私營機構對表觀遺傳學的投入不斷增加，預計將推動2023年至2030年的市場成長。 2025年2月，TruDiagnostic推出了津貼，提供40萬美元，用於支持從事DNA甲基化、長壽科學和診斷創新研究的研究人員。 NCBI於2022年發表的一項研究表明，表觀遺傳修飾在維持細胞穩態和基因組方面發揮關鍵作用，並提供有關病毒感染病因和發展的資訊。

表觀遺傳學診斷市場：分析概述

  • 就2024年的產品佔有率而言，試劑由於在表觀遺傳學研究中的使用率很高，將佔30.0%以上。
  • DNA 甲基化部分預計將以最快的速度成長，在 2025-2030 年的預測期內複合年成長率為 44.5%。
  • 2024 年，腫瘤學市場佔有率佔有率，而由於癌症發生率的增加，表觀遺傳學市場預計在預測期內也將成長。
  • 2024 年，學術研究領域佔據了最大的市場佔有率。這種成長可歸因於各公司增加研發資金以及政府支持措施等因素。
  • 由於主要參與者和先進的醫療基礎設施的存在，北美在 2024 年引領了表觀遺傳診斷市場。此外，預計在整個預測期內，不斷提高的意識和高額的研發支出將推動成長。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章表觀遺傳學診斷市場：變數、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 表觀遺傳學診斷市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
  • 表觀遺傳學診斷市場：產品線分析

第4章表觀遺傳學診斷市場：按產品分類的估計和趨勢分析

  • 特定於產品的儀表板
  • 表觀遺傳診斷市場：依產品進行的變異分析
  • 全球表觀遺傳診斷市場規模及產品趨勢分析（2018-2030）
  • 試劑
  • 套件
    • ChIP定序套件
    • 全基因組擴增試劑套件
    • 亞硫酸氫鹽轉化試劑套件
    • RNA定序套件
    • 其他
  • 裝置
  • 酵素
  • 服務

第5章表觀遺傳學診斷市場：依技術分類的預測與趨勢分析

  • 技術儀表板
  • 表觀遺傳診斷市場：依技術進行變異分析
  • 表觀遺傳診斷市場規模及技術趨勢分析（2018-2030）
  • DNA甲基化
    • 試劑
    • 套件
    • 裝置
    • 酵素
    • 服務
  • 組蛋白甲基化
    • 試劑
    • 套件
    • 裝置
    • 酵素
    • 服務
  • 組蛋白乙醯化
    • 試劑
    • 套件
    • 裝置
    • 酵素
    • 服務
  • 長鏈非編碼RNA（lncRNA）
    • 試劑
    • 套件
    • 裝置
    • 酵素
    • 服務
  • 微型RNA修飾
    • 試劑
    • 套件
    • 裝置
    • 酵素
    • 服務
  • 染色質結構
    • 試劑
    • 套件
    • 裝置
    • 酵素
    • 服務

第6章表觀遺傳學診斷市場：按應用的估計和趨勢分析

  • 用於特定目的的儀表板
  • 表觀遺傳診斷市場：依應用進行的變異分析
  • 全球表觀遺傳診斷市場規模及應用趨勢分析（2018-2030）
  • 瘤
    • 固態腫瘤
    • 液體腫瘤
  • 非腫瘤
    • 發炎性疾病
    • 代謝疾病
    • 感染疾病
    • 心血管疾病
    • 其他

第7章表觀遺傳學診斷市場：依最終用途的估計和趨勢分析

  • 按最終用途分類的儀表板
  • 表觀遺傳診斷市場：依最終用途進行的變異分析
  • 全球表觀遺傳診斷市場規模及趨勢分析（依最終用途分類）（2018-2030）
  • 學術研究
  • 臨床研究
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他用戶

第8章表觀遺傳學診斷市場：區域估計和趨勢分析

  • 市場儀表板：按地區
  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 表觀遺傳學診斷市場：按地區分類的關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要企業熱力圖分析（2024年）
  • 公司簡介
    • Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific, Inc.
    • Eisai Co. Ltd.
    • Novartis AG
    • Element Bisosciences, Inc.
    • Cantata Bio（Dovetail Genomics LLC.）
    • Illumina, Inc.
    • ValiRx Plc.
    • Abcam Ltd.
Product Code: GVR-2-68038-831-2

Epigenetics Diagnostics Market Growth & Trends:

The global epigenetics diagnostics market is anticipated to reach USD 39.15 billion by 2030 and is anticipated to expand at a CAGR of 15.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to increased investment, funding, and approvals for epigenetics research and development, and the increasing prevalence of MDD (Major Depressive Disorder). According to the World Health Organization (WHO), in 2023, approximately 5% of adults experienced depressive disorders. Furthermore, a study published by the National Center for Biotechnology Information (NCBI) in 2022 reported that around 280 million people worldwide are affected by MDD. Epigenetics' applications in drug discovery and development are growing, and genome sequencing is becoming more affordable. Additionally, advancements in technology related to epigenetic drug discovery contribute to this growth.

Additionally, an increase in investment from both public and private organizations in epigenetics is expected to drive market growth from 2023 to 2030. In February 2025, TruDiagnostic introduced the grant, which provides USD 400,000 in funding to support researchers working in DNA methylation, longevity science, and diagnostic innovation. A study published by NCBI in 2022 stated that epigenetic modification plays a crucial role in maintaining cellular homeostasis and the genome and provides information about the cause and development of virus infection.

Epigenetics Diagnostics Market Report Highlights:

  • Reagents dominated the product segment with more than 30.0% share in 2024, owing to their high usage in epigenetic research studies.
  • The DNA Methylation segment is expected to grow at the fastest CAGR of 44.5% over the forecast period 2025 - 2030.
  • The oncology segment held the largest market share in 2024, and with the increasing incidence of cancer, the epigenetic market is expected to grow over the forecast period.
  • The academic research segment held the largest market share in 2024. The growth is attributed to the factors such as increased funding for research and development by various companies and supportive initiatives from the government.
  • North America led the epigenetic diagnostics market in 2024 due to the presence of key market players and an advanced healthcare infrastructure. Additionally, increasing awareness along with significant R&D expenditure is expected to fuel growth throughout the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Technology
    • 2.2.3. Application
    • 2.2.4. End Use
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Epigenetics Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Epigenetics Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Epigenetics Diagnostics Market: Pipeline Analysis

Chapter 4. Epigenetics Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Epigenetics Diagnostics Market: Product Movement Analysis
  • 4.3. Global Epigenetics Diagnostics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Kits
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. ChIP Sequencing Kit
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Whole Genomic Amplification kit
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Bisulfite Conversion kit
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. RNA Sequencing kit
      • 4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million
  • 4.6. Instruments
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Enzymes
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Services
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Epigenetics Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Epigenetics Diagnostics Market: Technology Movement Analysis
  • 5.3. Epigenetics Diagnostics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. DNA Methylation
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Reagents
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Kits
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Instruments
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Enzymes
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Services
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Histone Methylation
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Reagents
      • 5.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Kits
      • 5.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Instruments
      • 5.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Enzymes
      • 5.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Services
      • 5.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Histone Acetylation
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Reagents
      • 5.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. Kits
      • 5.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Instruments
      • 5.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Enzymes
      • 5.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Services
      • 5.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Large non - coding RNA
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Reagents
      • 5.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. Kits
      • 5.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Instruments
      • 5.7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.5. Enzymes
      • 5.7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.6. Services
      • 5.7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. MicroRNA modification
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.2. Reagents
      • 5.8.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.3. Kits
      • 5.8.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.4. Instruments
      • 5.8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.5. Enzymes
      • 5.8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.6. Services
      • 5.8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Chromatin structure
    • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.2. Reagents
      • 5.9.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.3. Kits
      • 5.9.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.4. Instruments
      • 5.9.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.5. Enzymes
      • 5.9.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.6. Services
      • 5.9.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Epigenetics Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Epigenetics Diagnostics Market: Application Movement Analysis
  • 6.3. Global Epigenetics Diagnostics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Solid tumors
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Liquid tumors
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Non - Oncology
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Inflammatory diseases
      • 6.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Metabolic diseases
      • 6.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Infectious diseases
      • 6.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Cardiovascular diseases
      • 6.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Others
      • 6.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Epigenetics Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Epigenetics Diagnostics Market: End Use Movement Analysis
  • 7.3. Global Epigenetics Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Academic Research
    • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Clinical Research
    • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Hospitals & Clinics
    • 7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Pharmaceutical & Biotechnology Companies
    • 7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Other Users
    • 7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Epigenetics Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. Continuous bioprocessing market by Region: Key Takeaways
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Denmark
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Norway
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework/ reimbursement structure
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework/ reimbursement structure
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key company heat map analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Hoffmann- La Roche Ltd.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Thermo Fisher Scientific, Inc.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Eisai Co. Ltd.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Novartis AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Element Bisosciences, Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Cantata Bio (Dovetail Genomics LLC.)
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Illumina, Inc.
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. ValiRx Plc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Abcam Ltd.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Epigenetics Diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 6 Global epigenetics diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 9 North America epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 North America epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 12 U.S. epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Canada epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Mexico epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Mexico epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 25 Europe epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Europe epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Europe epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 28 Europe epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Germany epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 32 Germany epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 UK epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 UK epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 UK epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 UK epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 France epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 France epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 France epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 40 France epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Italy epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Italy epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Spain epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Spain epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Denmark epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Denmark epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Sweden epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Norway epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Norway epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 66 China epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 67 China epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 68 China epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 China epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Japan epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 71 Japan epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Japan epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 73 Japan epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 74 India epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 75 India epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 76 India epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 India epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Korea epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 79 South Korea epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Korea epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Korea epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Australia epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 83 Australia epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 84 Australia epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 85 Australia epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Thailand epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Thailand epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 88 Thailand epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Latin America epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 92 Latin America epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 93 Latin America epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Brazil epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 96 Brazil epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 97 Brazil epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 99 Argentina epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 100 Argentina epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 101 Argentina epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 103 MEA epigenetics diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 104 MEA epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 105 MEA epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 106 MEA epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 108 South Africa epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 109 South Africa epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 110 South Africa epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 116 UAE epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 117 UAE epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 118 UAE epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 121 Kuwait epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait epigenetics diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Epigenetics diagnostics market: market outlook
  • Fig. 10 Epigenetics diagnostics competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Epigenetics diagnostics market driver impact
  • Fig. 16 Epigenetics diagnostics market restraint impact
  • Fig. 17 Epigenetics diagnostics market strategic initiatives analysis
  • Fig. 18 Epigenetics diagnostics market: Technology movement analysis
  • Fig. 19 Epigenetics diagnostics market: Technology outlook and key takeaways
  • Fig. 20 DNA methylation market estimates and forecast, 2018 - 2030
  • Fig. 21 Histone methylation estimates and forecast, 2018 - 2030
  • Fig. 22 Histone acetylation market estimates and forecast, 2018 - 2030
  • Fig. 23 Large non - coding RNA estimates and forecast, 2018 - 2030
  • Fig. 24 MircoRNA modification market estimates and forecast, 2018 - 2030
  • Fig. 25 Chromatin structures estimates and forecast, 2018 - 2030
  • Fig. 26 Epigenetics diagnostics market: Product movement analysis
  • Fig. 27 Epigenetics diagnostics market: Product outlook and key takeaways
  • Fig. 28 Reagents market estimates and forecasts, 2018 - 2030
  • Fig. 29 Kits market estimates and forecasts,2018 - 2030
  • Fig. 30 ChIP Sequencing kit market estimates and forecasts,2018 - 2030
  • Fig. 31 Whole Genomic Amplification kit market estimates and forecasts,2018 - 2030
  • Fig. 32 Bisulfite Conversion kit market estimates and forecasts,2018 - 2030
  • Fig. 33 RNA Sequencing kit market estimates and forecasts,2018 - 2030
  • Fig. 34 Others market estimates and forecasts,2018 - 2030
  • Fig. 35 Instruments market estimates and forecasts,2018 - 2030
  • Fig. 36 Enzymes market estimates and forecasts,2018 - 2030
  • Fig. 37 Service market estimates and forecasts,2018 - 2030
  • Fig. 38 Epigenetics diagnostics market: Application movement analysis
  • Fig. 39 Epigenetics diagnostics market: Application outlook and key takeaways
  • Fig. 40 Oncology market estimates and forecasts, 2018 - 2030
  • Fig. 41 Solid tumors market estimates and forecasts, 2018 - 2030
  • Fig. 42 Liquid tumors market estimates and forecasts, 2018 - 2030
  • Fig. 43 Non - oncology market estimates and forecasts,2018 - 2030
  • Fig. 44 Inflammatory diseases market estimates and forecasts, 2018 - 2030
  • Fig. 45 Metabolic diseases market estimates and forecasts, 2018 - 2030
  • Fig. 46 Infectious diseases market estimates and forecasts, 2018 - 2030
  • Fig. 47 Cardiovascular diseases market estimates and forecasts, 2018 - 2030
  • Fig. 48 Others market estimates and forecasts, 2018 - 2030
  • Fig. 49 Epigenetics diagnostics market: End use movement analysis
  • Fig. 50 Epigenetics diagnostics market: End use outlook and key takeaways
  • Fig. 51 Academic research market estimates and forecasts, 2018 - 2030
  • Fig. 52 Clinical research market estimates and forecasts, 2018 - 2030
  • Fig. 53 Hospitals & clinics market estimates and forecasts, 2018 - 2030
  • Fig. 54 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 55 Other users market estimates and forecasts, 2018 - 2030
  • Fig. 56 Global epigenetics diagnostics market: Regional movement analysis
  • Fig. 57 Global epigenetics diagnostics market: Regional outlook and key takeaways
  • Fig. 58 North America market estimates and forecasts, 2018 - 2030
  • Fig. 59 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 60 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 61 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 62 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 63 UK market estimates and forecasts, 2018 - 2030
  • Fig. 64 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 65 France market estimates and forecasts, 2018 - 2030
  • Fig. 66 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 67 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 68 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 70 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 71 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 72 China market estimates and forecasts, 2018 - 2030
  • Fig. 73 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 74 India market estimates and forecasts, 2018 - 2030
  • Fig. 75 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 76 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 77 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 78 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 79 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 80 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 81 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 82 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 83 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 84 Kuwait market estimates and forecasts, 2018 - 2030